JP7072385B2 - ニューモシスチス肺炎を診断、予測又はモニタリングするための手段 - Google Patents

ニューモシスチス肺炎を診断、予測又はモニタリングするための手段 Download PDF

Info

Publication number
JP7072385B2
JP7072385B2 JP2017553984A JP2017553984A JP7072385B2 JP 7072385 B2 JP7072385 B2 JP 7072385B2 JP 2017553984 A JP2017553984 A JP 2017553984A JP 2017553984 A JP2017553984 A JP 2017553984A JP 7072385 B2 JP7072385 B2 JP 7072385B2
Authority
JP
Japan
Prior art keywords
seq
gene
irobeti
rna
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017553984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018511339A (ja
JP2018511339A5 (enExample
Inventor
アレクサンドル・アラニオ
ステファン・ブルターニュ
フランソワーズ・ドロメル
オードゥ・スターニー－ルクレール
バンジャマン・オメル
マリオン・ベナズラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of JP2018511339A publication Critical patent/JP2018511339A/ja
Publication of JP2018511339A5 publication Critical patent/JP2018511339A5/ja
Application granted granted Critical
Publication of JP7072385B2 publication Critical patent/JP7072385B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2017553984A 2015-04-15 2016-04-15 ニューモシスチス肺炎を診断、予測又はモニタリングするための手段 Active JP7072385B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305562 2015-04-15
EP15305562.9 2015-04-15
PCT/EP2016/058355 WO2016166287A1 (en) 2015-04-15 2016-04-15 Means for diagnosing, predicting or monitoring pneumocystis pneumonia

Publications (3)

Publication Number Publication Date
JP2018511339A JP2018511339A (ja) 2018-04-26
JP2018511339A5 JP2018511339A5 (enExample) 2019-05-23
JP7072385B2 true JP7072385B2 (ja) 2022-05-20

Family

ID=52946502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017553984A Active JP7072385B2 (ja) 2015-04-15 2016-04-15 ニューモシスチス肺炎を診断、予測又はモニタリングするための手段

Country Status (7)

Country Link
US (2) US11236390B2 (enExample)
EP (1) EP3283643B8 (enExample)
JP (1) JP7072385B2 (enExample)
CN (1) CN107636172B (enExample)
CA (1) CA2982508A1 (enExample)
DK (1) DK3283643T3 (enExample)
WO (1) WO2016166287A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090637A1 (en) * 2001-05-08 2002-11-14 Shima Seiki Mfg., Ltd. Knit wear with collar knit by flat knitting machine and method of knitting it

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016166287A1 (en) * 2015-04-15 2016-10-20 Institut Pasteur Means for diagnosing, predicting or monitoring pneumocystis pneumonia
CN107354221A (zh) * 2017-08-28 2017-11-17 合肥千麦医学检验所有限公司 耶氏肺孢子菌的pcr检测试剂盒
KR102026553B1 (ko) * 2018-01-08 2019-09-27 조선대학교산학협력단 다복제유전자를 이용한 쯔쯔가무시병의 진단방법
CN109251992A (zh) * 2018-09-13 2019-01-22 昆明医科大学第附属医院 一种检测耶氏肺孢子菌的lamp引物组合物和方法
CN109346174A (zh) * 2018-10-24 2019-02-15 南昌大学第二附属医院 非人类免疫性缺陷病毒感染患者pcp风险评估系统
CN109666755A (zh) * 2018-12-25 2019-04-23 北京卓诚惠生生物科技股份有限公司 用于检测侵袭性真菌的核酸试剂、试剂盒、系统及方法
CN110408717A (zh) * 2019-07-23 2019-11-05 四川省农业科学院生物技术核技术研究所 灵芝属线粒体rns基因的特异扩增引物及其应用
WO2021039540A1 (ja) * 2019-08-23 2021-03-04 富士フイルム和光純薬株式会社 ニューモシスチス・イロベチイ検出用プライマー対、これを用いたニューモシスチス・イロベチイの検出方法及びそのための試薬キット
CN111424101A (zh) * 2020-03-30 2020-07-17 广州市第八人民医院 一种用于定量检测耶氏肺孢子菌的试剂盒和方法
CN111455094B (zh) * 2020-06-17 2020-09-08 圣湘生物科技股份有限公司 检测深部感染真菌的组合物、试剂盒、用途及其方法
CN113088579B (zh) * 2021-03-16 2022-03-22 广州医科大学附属第一医院 一种用于定性检测耶氏肺孢子菌的试剂盒和方法
ES2933149A1 (es) * 2021-07-28 2023-02-01 Fundacion Para El Fomento De La Investig Sanitaria Y Biomedica De La Comunitat Valenciana Fisabio METODO in vitro PARA EL DIAGNOSTICO DE UNA INFECCION POR Pneumocystis jirovecii
CN115029471A (zh) * 2022-05-27 2022-09-09 大连干细胞与精准医学创新研究院 一种基于数字pcr技术检测耶氏肺孢子菌的试剂盒及检测方法
CN115820921B (zh) * 2022-12-19 2024-07-05 领航基因科技（杭州）有限公司 三种肺侵袭性真菌检测的引物探针组合及其数字pcr试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110189676A1 (en) * 2008-10-03 2011-08-04 Hall Thomas A Compositions for use in identification of fungi
WO2014071946A1 (en) * 2012-11-07 2014-05-15 Statens Serum Institut Diagnostic pcr primers enabling exhaustive detection of non-human eukaryotic ssu rdna in human clinical samples
WO2016166287A1 (en) * 2015-04-15 2016-10-20 Institut Pasteur Means for diagnosing, predicting or monitoring pneumocystis pneumonia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Clin. Microbiol. Infect.，2011年，Vol. 17，p. 1531-1537
J. Clin. Microbiol.，2013年，Vol. 51，p. 136-141

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090637A1 (en) * 2001-05-08 2002-11-14 Shima Seiki Mfg., Ltd. Knit wear with collar knit by flat knitting machine and method of knitting it

Also Published As

Publication number Publication date
EP3283643B8 (en) 2020-06-10
CN107636172A (zh) 2018-01-26
WO2016166287A1 (en) 2016-10-20
EP3283643A1 (en) 2018-02-21
DK3283643T3 (da) 2020-05-18
US11236390B2 (en) 2022-02-01
US20180127825A1 (en) 2018-05-10
CA2982508A1 (en) 2016-10-20
EP3283643B1 (en) 2020-04-15
JP2018511339A (ja) 2018-04-26
CN107636172B (zh) 2021-11-16
US20220119886A1 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
JP7072385B2 (ja) ニューモシスチス肺炎を診断、予測又はモニタリングするための手段
US9469875B2 (en) Methods for detection of depressive disorders
Shipitsyna et al. Evaluation of polymerase chain reaction assays for the diagnosis of Trichomonas vaginalis infection in Russia
EP3394291B1 (en) Triage biomarkers and uses therefor
WO2017054325A1 (zh) 乳腺癌联合诊断标志物及检测试剂盒
JP2025087867A (ja) 子宮内膜症に関連するミトコンドリアｄｎａ欠失
CN110229899B (zh) 用于结直肠癌早期诊断或预后预测的血浆标记物组合
JP2026012758A (ja) 患者における医療関連感染の発生リスクを判定するための方法
KR20230117152A (ko) 코로나바이러스 감염 발생 위험이 증가한 대상체의 식별 및 이의 치료 방법
US12227808B2 (en) Compostions and methods for diagnosing lung cancers using gene expression profiles
US20200277655A1 (en) New tools for assessing fimh blockers therapeutic efficiency
CN115803450A (zh) 特应性皮炎的重症度的检测方法
JP2004151003A (ja) Ｍｕｃ１およびケラチン１９の検査方法
LU500371B1 (en) Application of GAS5 in the diagnosis of severe asthma
CN111712583A (zh) 使用多拷贝基因诊断恙虫病的方法
WO2019062429A1 (zh) 分子标记物tcons_00016233、试剂盒及应用
Hamet et al. Prevalence and bio-clinical characterisation of Trichomonas vaginalis infection in a large cohort of French patients screened using a molecular syndromic panel for sexually transmitted infections
US20250298015A1 (en) Diagnostic method of detecting inflammation biomarker(s)
WO2022186296A1 (ja) アトピー性皮膚炎の症度悪化の検出方法
JP2023038883A (ja) ＳＡＲＳ－ＣｏＶ－２の検出方法
CN119842939A (zh) 耐万古霉素肠球菌检测试剂盒以及检测方法
JP2014093962A (ja) 白血球抗原マーカーを用いた検査方法
KR20130102431A (ko) Ａ형 인플루엔자 ｈ１ｎ１ 바이러스 검출용 키트

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190415

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190415

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200309

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210830

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220411

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220510

R150 Certificate of patent or registration of utility model

Ref document number: 7072385

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250